tiprankstipranks
Advertisement
Advertisement
Cybin’s Helus Pharma Posts Strong Phase 2 Data for HLP004 in Hard-to-Treat Anxiety
PremiumCompany AnnouncementsCybin’s Helus Pharma Posts Strong Phase 2 Data for HLP004 in Hard-to-Treat Anxiety
19d ago
Helus Pharma announces results in Phase 2 signal detection study of HLP004
Premium
The Fly
Helus Pharma announces results in Phase 2 signal detection study of HLP004
19d ago
Cybin Corrects Exhibit References in Form 6-K to Align With Active F-10 Shelf
Premium
Company Announcements
Cybin Corrects Exhibit References in Form 6-K to Align With Active F-10 Shelf
19d ago
Cybin (Helus Pharma) Names Veteran Pharma Executive Michael Cola as CEO to Drive CNS Growth
PremiumCompany AnnouncementsCybin (Helus Pharma) Names Veteran Pharma Executive Michael Cola as CEO to Drive CNS Growth
1M ago
Helus Pharma’s Short-Acting Depression Drug Shows Durable Benefit in Phase 2a Trial
Premium
Company Announcements
Helus Pharma’s Short-Acting Depression Drug Shows Durable Benefit in Phase 2a Trial
1M ago
Helus Pharma announces Phase 2a study of SPL026 met primary endpoint
Premium
The Fly
Helus Pharma announces Phase 2a study of SPL026 met primary endpoint
1M ago
Helus Pharma Taps Industry Veteran Michael Cola as CEO Ahead of Key Trial Milestones
PremiumCompany AnnouncementsHelus Pharma Taps Industry Veteran Michael Cola as CEO Ahead of Key Trial Milestones
1M ago
Helus Pharma appoints Cola as CEO
Premium
The Fly
Helus Pharma appoints Cola as CEO
1M ago
Psychedelic: Analyst initiates Definium, Helus with Buy ratings
Premium
The Fly
Psychedelic: Analyst initiates Definium, Helus with Buy ratings
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100